SMN2 and proximal spinal muscular atrophy: It is worth noting that the SMA-Cas12a-strip assay could qualitatively detect the homozygous deletion of SMN1 exon 7, which accounts for more than 95% of SMA patients, but the copy numbers of SMN1 and SMN2 and the rare mutations in SMN1 are beyond this assay’s capacity.